Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of $160.44 billion as of April 28, 2026. Its market cap has increased by 24.32% in one year.

Market Cap

160.44B

Enterprise Value

173.39B

1-Year Change

24.32%

Ranking

#86

Market Cap Chart

Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $160.44B, an increase of 16,387.55%. That is a compound annual growth rate of 20.46%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	160.47B	5.37%
Dec 31, 2025	152.28B	32.28%
Dec 31, 2024	115.12B	14.04%
Dec 29, 2023	100.94B	-6.25%
Dec 30, 2022	107.68B	18.22%
Dec 31, 2021	91.08B	24.72%
Dec 31, 2020	73.03B	-11.17%
Dec 31, 2019	82.21B	1.60%
Dec 31, 2018	80.92B	-13.53%
Dec 29, 2017	93.58B	-0.81%
Dec 30, 2016	94.34B	-35.31%
Dec 31, 2015	145.83B	2.55%
Dec 31, 2014	142.21B	23.49%
Dec 31, 2013	115.15B	106.93%
Dec 31, 2012	55.65B	81.01%
Dec 30, 2011	30.74B	4.49%
Dec 31, 2010	29.42B	-24.44%
Dec 31, 2009	38.94B	-16.37%
Dec 31, 2008	46.56B	8.73%
Dec 31, 2007	42.82B	43.43%
Dec 29, 2006	29.86B	24.03%
Dec 30, 2005	24.07B	58.92%
Dec 31, 2004	15.15B	28.36%
Dec 31, 2003	11.80B	76.49%
Dec 31, 2002	6.69B	6.07%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Johnson & Johnson	542.44B
AbbVie	349.12B
AstraZeneca	293.62B
Novartis AG	277.41B
Merck & Co.	272.25B
Amgen	183.59B
Novo Nordisk	183.47B
Pfizer	152.39B

Market Cap Rankings